2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro; J. Bohlius; David A. Cameron; Lissandra Dal Lago; J. Peter Donnelly; N. Kearney; G. H. Lyman; R. Pettengell; V. C. Tjan-Heijnen; J. Walewski; Damien C. Weber; C. Zielinski

doi:10.1016/j.ejca.2010.10.013

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro^*, J. Bohlius, David A. Cameron, Lissandra Dal Lago, J. Peter Donnelly, N. Kearney, G. H. Lyman, R. Pettengell, V. C. Tjan-Heijnen, J. Walewski, Damien C. Weber, C. Zielinski

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	8-32
Journal	European Journal of Cancer
Volume	47
Issue number	1
DOIs	https://doi.org/10.1016/j.ejca.2010.10.013
Publication status	Published - Jan 2011

Keywords

Antineoplastic agents
Filgrastim
Granulocyte colony-stimulating factor
Lenograstim
Neoplasms
Neutropenia
Pegfilgrastim
Guideline

Access to Document

10.1016/j.ejca.2010.10.013

Cite this

Aapro, M. S., Bohlius, J., Cameron, D. A., Dal Lago, L., Donnelly, J. P., Kearney, N., Lyman, G. H., Pettengell, R., Tjan-Heijnen, V. C., Walewski, J., Weber, D. C., & Zielinski, C. (2011). 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European Journal of Cancer, 47(1), 8-32. https://doi.org/10.1016/j.ejca.2010.10.013

Aapro, M.S. ; Bohlius, J. ; Cameron, David A. ; Dal Lago, Lissandra ; Donnelly, J. Peter ; Kearney, N. ; Lyman, G. H. ; Pettengell, R. ; Tjan-Heijnen, V. C. ; Walewski, J. ; Weber, Damien C. ; Zielinski, C. / 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. In: European Journal of Cancer. 2011 ; Vol. 47, No. 1. pp. 8-32.

@article{b50a01d93667458ba3ca0d2d211c59ad,

title = "2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours",

keywords = "Antineoplastic agents, Filgrastim, Granulocyte colony-stimulating factor, Lenograstim, Neoplasms, Neutropenia, Pegfilgrastim, Guideline",

author = "M.S. Aapro and J. Bohlius and Cameron, {David A.} and {Dal Lago}, Lissandra and Donnelly, {J. Peter} and N. Kearney and Lyman, {G. H.} and R. Pettengell and Tjan-Heijnen, {V. C.} and J. Walewski and Weber, {Damien C.} and C. Zielinski",

year = "2011",

month = jan,

doi = "10.1016/j.ejca.2010.10.013",

language = "English",

volume = "47",

pages = "8--32",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

number = "1",

}

Aapro, MS, Bohlius, J, Cameron, DA, Dal Lago, L, Donnelly, JP, Kearney, N, Lyman, GH, Pettengell, R, Tjan-Heijnen, VC, Walewski, J, Weber, DC & Zielinski, C 2011, '2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours', European Journal of Cancer, vol. 47, no. 1, pp. 8-32. https://doi.org/10.1016/j.ejca.2010.10.013

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. / Aapro, M.S.; Bohlius, J.; Cameron, David A.; Dal Lago, Lissandra; Donnelly, J. Peter; Kearney, N.; Lyman, G. H.; Pettengell, R.; Tjan-Heijnen, V. C.; Walewski, J.; Weber, Damien C.; Zielinski, C.

In: European Journal of Cancer, Vol. 47, No. 1, 01.2011, p. 8-32.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

AU - Aapro, M.S.

AU - Bohlius, J.

AU - Cameron, David A.

AU - Dal Lago, Lissandra

AU - Donnelly, J. Peter

AU - Kearney, N.

AU - Lyman, G. H.

AU - Pettengell, R.

AU - Tjan-Heijnen, V. C.

AU - Walewski, J.

AU - Weber, Damien C.

AU - Zielinski, C.

PY - 2011/1

Y1 - 2011/1

KW - Antineoplastic agents

KW - Filgrastim

KW - Granulocyte colony-stimulating factor

KW - Lenograstim

KW - Neoplasms

KW - Neutropenia

KW - Pegfilgrastim

KW - Guideline

U2 - 10.1016/j.ejca.2010.10.013

DO - 10.1016/j.ejca.2010.10.013

M3 - Article

C2 - 21095116

VL - 47

SP - 8

EP - 32

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 1

ER -

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European Journal of Cancer. 2011 Jan;47(1):8-32. https://doi.org/10.1016/j.ejca.2010.10.013